Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cytek Biosciences Inc
(NQ:
CTKB
)
5.350
+0.040 (+0.75%)
Streaming Delayed Price
Updated: 12:04 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytek Biosciences Inc
< Previous
1
2
3
4
Next >
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
October 19, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 17, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Via
Benzinga
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
October 17, 2023
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of Cytek Biosciences Dropped This Week
May 12, 2023
Cytek grew revenue and losses in the first quarter.
Via
The Motley Fool
Where Cytek Biosciences Stands With Analysts
May 10, 2023
Via
Benzinga
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
September 27, 2023
Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
September 14, 2023
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Recap: Cytek Biosciences Q1 Earnings
May 09, 2023
Via
Benzinga
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
September 20, 2023
Company to Lead Symposiums at ICCS and ESCCA
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
August 28, 2023
Sales Organization Enhanced, Platform Organization Created
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
August 10, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
July 20, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
May 31, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
July 19, 2023
Via
Benzinga
Cytek Biosciences Announces $50 Million Stock Repurchase Program
May 19, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
May 16, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 10, 2023
Via
Benzinga
Cytek Biosciences Reports First Quarter 2023 Financial Results
May 09, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 26, 2023
Via
Benzinga
Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 26, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders.
Via
Benzinga
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
April 20, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Introduces New 20-Color AML Panel
March 07, 2023
Optimized for Cytek Cell Analysis Systems; Single-Tube Panel Accelerates Acute Myeloid Leukemia Research and MRD Detection
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
March 03, 2023
Via
Benzinga
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
February 28, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 14, 2023
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.